Practice, Knowledge, and Barriers for Screening of Hepatocellular Carcinoma Among High-Risk Chinese Patients
Author:
Publisher
Ubiquity Press, Ltd.
Subject
General Medicine
Reference40 articles.
1. Surveillance for hepatocellular carcinoma: in whom and how?;El-Serag;Therap Adv Gastroenterol,2011
2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
3. Liver cancer incidence and mortality in China, 2009;Chen;Chin J Cancer,2013
4. Randomized controlled trial of screening for hepatocellular carcinoma;Zhang;J Cancer Res Clin Oncol,2004
5. Liver cancer working group report;Kudo;Jpn J Clin Oncol,2010
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. mhealth-based interventions to improving liver cancer screening among high-risk populations: a study protocol for a randomized controlled trial;BMC Public Health;2024-09-13
2. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study;The Lancet Gastroenterology & Hepatology;2024-06
3. Existing knowledge, myths, and perceptions about hepatitis B and liver cancer within highly impacted immigrant communities;Journal of Virus Eradication;2024-06
4. Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysis;Journal of Comparative Effectiveness Research;2024-04
5. The Influence of Medical Subspecialty on the Adherence to Hepatocellular Carcinoma Surveillance in Patients with Chronic Hepatitis B;Siriraj Medical Journal;2024-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3